Ashok Singh

Highly respected in the industry for using technology to solve complex healthcare problems, Mr. Singh is responsible for the strategy and ongoing development of Lynk, our innovative technology platform. Because of his strong background in building complex patient engagement and data analytics platforms—and deep understanding of the patient journey—Mr. Singh continually looks for new ways to improve the tools and solutions we can offer to our partners. He was executing big data projects before AI was popular, and his eye for what’s next positions our company—and our clients—for growth.

Before joining PharmaCord, Mr. Singh was the Chief Information Officer at Omnicare, Inc., a former Fortune 500 healthcare services company. There, his comprehensive technology strategy for consolidating Omnicare’s disparate pharmacy systems resulted in $75 million in annual savings. In his time as Senior Vice President of Information Technology at Aurora Health Care, he led a three-year, $200 million deployment of Epic Electronic Health Record system, making it one of the most transformative technology deployments in the provider healthcare space. He has also served as Vice President of IT, Pharmacy & Corporate Systems at CVS Health, a Fortune 10 healthcare services company.

Companies thirst for significant growth and a strategy that’ll land them stability. Sahney delivers. Well-known for transforming four healthcare companies, Sahney today is the founder and CEO of PharmaCord, one of the fastest growing—and top rated—companies in the patient services industry. His vision has grown the company from concept to 500+ employees in just under 5 years.

Sahney accomplished this purpose-driven growth through intellect, yes, but also a commitment to being kind. Previously, Sahney ascended the ranks at Cincinnati-based Omnicare to become CEO, and led a blockbuster sale of the company for $12.7 billion to CVS Health, while generating a 49% total shareholder return. As the founder of RxCrossroads, a specialty pharmaceutical services company, he drove operations from start-up to sale in four years (for $240 million).

Because of Mr. Sahney’s leadership at Omnicare he was named “Best performing rookie CEOs of the Fortune 500.” Hardly a rookie anymore, Sahney is poised to continue evolving and challenging the healthcare industry.

Mr. Lee is a versatile corporate finance executive, have held senior roles within finance, strategy, investor relations and product development across a wide range of public and private companies. At PharmaCord, he is responsible for the finance, human resources and marketing functions. He has helped guide the development of these critical support functions through various stages of PharmaCord’s growth journey.

Before joining PharmaCord, Mr. Lee led the product and business development efforts for CVS Health’s long-term care business. While there, he developed many solutions, including one for payers designed to increase quality of care and lower costs for senior living residents, while positioning CVS Health for accelerated pharmacy growth. Mr. Lee transitioned to CVS Health from Omnicare, where he led strategy and investor relations amid the company’s $12.7 billion sale to CVS Health. While at Omnicare, he directed several key initiatives, including unlocking over $1.2 billion in market capitalization by adopting an “adjusted cash earnings” methodology, which better conveyed the company’s strong cash flows.  For his many contributions, he was named to the 2013 All-America Executive Team (Institutional Investor).  Mr. Lee has also held finance, operations, and investor relations roles in TriNet Group, Inc. and Signet Jewelers.

A dynamic solution developer and operations lead, Ms. Von Dohren develops business opportunities with new and existing clients, and provides executive oversight for operations of a portfolio of PharmaCord’s client programs. Through her leadership, she is responsible for growing and evolving services for more than one-third of the PharmaCord’s programs. Her dedication to improving pharmaceutical access, and 20+ years of leadership in patient services are incredibly valuable to our clients.

Over the years Ms. Von Dohren has worked with both providers and manufacturers. Most recently, she served as Director of Patient Services at CSL Behring. While there, she reshaped their domestic patient services strategy. Prior to that, she held a VP role at both RxCrossroads by McKesson and Director in several capacities at Merck. In her roles at Merck she oversaw all patient access and patient assistance programs, and served as a marketing director in the oncology franchise.

A registered pharmacist and patient services executive known for delivering results, Mr. Hileman supports PharmaCord’s operations, business development, and strategic initiatives  —focused on supporting specialty products and complex disease states. In his career, he has launched or transitioned over 50 patient support programs. Under his pharmaceutical experience and leadership, PharmaCord is developing partnerships with biopharma manufacturers to drive the commercial success of their specialty medications.

Mr. Hileman has developed strategies and operational improvements in both startups and Fortune 500 companies. As a senior executive with Omnicare he led operations within the Specialty Care Group, Long Term Care Group as well as commercial operations. Before this position, he was a founding executive of RxCrossroads, a leading commercialization services company. Throughout his 30+ career in healthcare services, he has been featured in numerous trade publications and has spoken at a variety of conferences about commercialization services.

An accomplished pharmaceutical leader, Mr. Brown oversees operations, organic growth and business development for PharmaCord. His insights, experience and dedication to improving patients’ lives are key drivers in our company’s ongoing success. He brings to our company 20 years of experience in maximizing commercialization, distribution, and access to pharmaceuticals.

Mr. Brown has spent his 20+ year career in the industry, leading RxCrossroads through two acquisitions, and serving in leadership at CVS Health, McKesson, and Omnicare Specialty Care Group, where he successfully delivered revenue, operational improvements and market share growth. Most recently, he served as Vice President & General Manager for McKesson’s pharmacy services. He also has more than 10 years of experience in leading the operations and business development efforts for Cardinal Health Specialty Solutions, where he helped pioneer and lead many new service offerings.

Well-versed in the legal and operational aspects of patient services, Ms. Padgett joins her colleagues to create unique service solutions and serves as the head of legal affairs for PharmaCord. In her 20+ year career, she has designed and contracted 400+ service programs for top-performing companies in the healthcare industry.

Her distinguished career has involved leadership roles in patient services, reimbursement, legal, and compliance. Prior to joining PharmaCord, Ms. Padgett was a VP at US WorldMeds, leading the management of patient access programs, field reimbursement, government accounts and contracting. She also had a long career with RxCrossroads, an Omnicare Specialty Company, serving in many leadership roles, including General Manager.

As our technology leader, Mr. Liu oversees the development of our technology platforms and solutions. He is the pioneer of PharmaCord Lynk, our proprietary technology platform. Mr. Liu has an extraordinary understanding of both technology’s impact on the patient journey and the specialty pharmaceuticals market. It’s from this strategic knowledge that he is designing innovative solutions for our clients. Having built several mission-critical, patient-facing systems in his career, he knows how to deliver next-gen solutions. PharmaCord’s clients also benefit from his experience in securing patient data and enterprise-level architecture for healthcare.

Before joining PharmaCord, Mr. Liu was a Director and Executive Consultant for CVS Caremark, a Fortune 10 healthcare services company. He also served as Technical Architect at United Air Lines, where he oversaw information technology strategy and planning as well as software development.

Ms. Roberts is a seasoned operational leader, known for her work ethic and dedication to results. As a founding team member of PharmaCord, she develops strategies to enhance employee performance and plays a key role in business development and marketing efforts. Ms. Roberts leads the implementation and management of corporate best practices—so our clients receive industry leading service. She was also instrumental in developing our state-of-the-art facility in Jeffersonville, IN.

Before joining PharmaCord, Ms. Roberts served as a Client Service Associate for Merrill Lynch, and Executive Assistant to the President and CEO of Omnicare, a CVS Health company. She also spent a decade as a Territory Administrator of Blockbuster—and was one of the final four employees of the former movie rental giant.

A stalwart entrepreneur and investor, Mr. Karp brings deep experience in healthcare and successful corporate operations to PharmaCord. Mr. Karp is the current owner and operator of America Place and Kaden Companies, comprising more than one million square feet of building space and home to over 30 businesses across a variety of industries in the Kentucky and Indiana area.

Mr. Karp was CEO and owner of RxCrossroads, which was sold to Omnicare in 2005 for $240 million. His foresight and experience in the medical field was instrumental in the development of MDI’s transportation and cold-storage services, making MDI one of the country’s top frozen plasma transportation and storage companies. Mr. Karp is a decorated Army veteran.